CAS No. |
53155-25-2 |
中文名称 |
(1R,2R,4aS,6aS,6bR,8aR,10S,11R,12aR,12bR,14bS)-1,10,11-三羟基-1,2,6a,6b,9,9,12a-七甲基-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-十八氢并苯并菲-4a(2H)-羧酸 |
英文名称 |
(1R,2R,4aS,6aS,6bR,8aR,10S,11R,12aR,12bR,14bS)-1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydropicene-4a(2H)-carboxylic acid |
别名 |
CHEBI:67914 | NSC733507 | NSC-733507 | MS-29089 | (1S,2S,4AS,6AS,6AS,6BR,8AR,10S,11R,12AS,14BS)-1,2,6A,6B,9,9,12A-HEPTAMETHYL-1,10,11-TRIS(OXIDANYL)-2,3,4,5,6,6A,7,8,8A,10,11,12,13,14B-TETRADECAHYDROPICENE-4A-CARBOXYLIC ACID | Q27136388 | AKOS032948559 | |
标准英文名 |
(1R,2R,4aS,6aS,6bR,8aR,10S,11R,12aR,12bR,14bS)-1,10,11-trihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydropicene-4a(2H)-carboxylic acid |
MDL No. |
MFCD09970922 |
分子式 |
C30H48O5 |
分子量 |
488.71
|
精确分子量 |
488.35
|
SMILES |
C[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@]1(C)O |
标准SMILES |
CC1(C)[C@@H]2CC[C@]3(C)[C@H](CC=C4[C@H]5[C@@](CC[C@@]34C)(CC[C@@H](C)[C@@]5(C)O)C(O)=O)[C@@]2(C)C[C@@H](O)[C@H]1O |
用途 |
Euscaphic acid exhibits anti-hepatocellular carcinoma activity; it is used for content determination, identification, and pharmacological studies; it shows significant cytotoxic effects against breast cancer, lung cancer, and colon cancer cells with minimal toxicity to non-tumor cells; it acts as a DNA polymerase inhibitor (IC50: 61 μM for calf DNA polymerase α; 108 μM for rat DNA polymerase β); it induces apoptosis and cell cycle arrest in nasopharyngeal carcinoma (NPC) cells by suppressing the PI3K/AKT/mTOR signaling pathway. |
InChIKey |
OXVUXGFZHDKYLS-QUFHAEKXSA-N |